BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mitsiki E, Papageorgiou AC, Iyer S, Thiyagarajan N, Prior SH, Sleep D, Finnis C, Acharya KR. Structures of native human thymidine phosphorylase and in complex with 5-iodouracil. Biochem Biophys Res Commun 2009;386:666-70. [PMID: 19555658 DOI: 10.1016/j.bbrc.2009.06.104] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Westarp S, Kaspar F, Neubauer P, Kurreck A. Industrial potential of the enzymatic synthesis of nucleoside analogs: existing challenges and perspectives. Current Opinion in Biotechnology 2022;78:102829. [DOI: 10.1016/j.copbio.2022.102829] [Reference Citation Analysis]
2 Satpathy SS, Sahu SN, Pattanayak SK, Mohanty C. A molecular docking and dynamics study to screen phytochemicals that target mutant thymidine phosphorylase for colon cancer therapy. Journal of the Indian Chemical Society 2022. [DOI: 10.1016/j.jics.2022.100476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Stary D, Kukułowicz J, Góral I, Baltrukevich H, Barbasevich M, Godyń J, Bajda M. Multilevel virtual screening approach for discovery of thymidine phosphorylase inhibitors as potential anticancer agents. Journal of Molecular Structure 2022;1249:131648. [DOI: 10.1016/j.molstruc.2021.131648] [Reference Citation Analysis]
4 Warfield BM, Reigan P. Multifunctional role of thymidine phosphorylase in cancer. Trends in Cancer 2022. [DOI: 10.1016/j.trecan.2022.01.018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Aknin K, Bontemps A, Farce A, Merlet E, Belmont P, Helissey P, Chavatte P, Sari MA, Giorgi-Renault S, Desbène-Finck S. Polycyclic nitrogen heterocycles as potential thymidine phosphorylase inhibitors: synthesis, biological evaluation, and molecular docking study. J Enzyme Inhib Med Chem 2022;37:252-68. [PMID: 34933639 DOI: 10.1080/14756366.2021.2001806] [Reference Citation Analysis]
6 Karamitros CS, Somody CM, Agnello G, Rowlinson S. Engineering of the Recombinant Expression and PEGylation Efficiency of the Therapeutic Enzyme Human Thymidine Phosphorylase. Front Bioeng Biotechnol 2021;9. [DOI: 10.3389/fbioe.2021.793985] [Reference Citation Analysis]
7 Srivastava P, Shende S, Mandal K. Deciphering the Pathogenic Nature of Two de novo Sequence Variations in a Patient with Shprintzen-Goldberg Syndrome. Mol Syndromol 2021;12:141-7. [PMID: 34177429 DOI: 10.1159/000514125] [Reference Citation Analysis]
8 Kamatani N, Jinnah H, Hennekam RC, van Kuilenburg AB. Purine and Pyrimidine Metabolism. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics 2021. [DOI: 10.1016/b978-0-12-812535-9.00006-6] [Reference Citation Analysis]
9 Tozer T, Heale K, Manto Chagas C, de Barros ALB, Alisaraie L. Interdomain twists of human thymidine phosphorylase and its active-inactive conformations: Binding of 5-FU and its analogues to human thymidine phosphorylase versus dihydropyrimidine dehydrogenase. Chem Biol Drug Des 2019;94:1956-72. [PMID: 31356728 DOI: 10.1111/cbdd.13596] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
10 Zhang B, Shu M, Xu C, An C, Wang R, Lin Z. Virtual Screening, Docking, Synthesis and Bioactivity Evaluation of Thiazolidinediones as Potential PPARγ Partial Agonists for Preparation of Antidiabetic Agents. LDDD 2019;16:608-17. [DOI: 10.2174/1570180815666180827123512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 de Moura Sperotto ND, Deves Roth C, Rodrigues-junior VS, Ev Neves C, Reisdorfer Paula F, da Silva Dadda A, Bergo P, Freitas de Freitas T, Souza Macchi F, Moura S, Duarte de Souza AP, Campos MM, Valim Bizarro C, Santos DS, Basso LA, Machado P. Design of Novel Inhibitors of Human Thymidine Phosphorylase: Synthesis, Enzyme Inhibition, in Vitro Toxicity, and Impact on Human Glioblastoma Cancer. J Med Chem 2019;62:1231-45. [DOI: 10.1021/acs.jmedchem.8b01305] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
12 Taha M, Rashid U, Imran S, Ali M. Rational design of bis-indolylmethane-oxadiazole hybrids as inhibitors of thymidine phosphorylase. Bioorganic & Medicinal Chemistry 2018;26:3654-63. [DOI: 10.1016/j.bmc.2018.05.046] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
13 Iftikhar F, Yaqoob F, Tabassum N, Jan MS, Sadiq A, Tahir S, Batool T, Niaz B, Ansari FL, Choudhary MI, Rashid U. Design, synthesis, in-vitro thymidine phosphorylase inhibition, in-vivo antiangiogenic and in-silico studies of C-6 substituted dihydropyrimidines. Bioorg Chem 2018;80:99-111. [PMID: 29894893 DOI: 10.1016/j.bioorg.2018.05.026] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 9.0] [Reference Citation Analysis]
14 Balaev VV, Prokofev II, Gabdoulkhakov AG, Betzel C, Lashkov AA. Crystal structure of pyrimidine-nucleoside phosphorylase from Bacillus subtilis in complex with imidazole and sulfate. Acta Crystallogr F Struct Biol Commun 2018;74:193-7. [PMID: 29633966 DOI: 10.1107/S2053230X18002935] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Zhao S, Li K, Jin Y, Lin J. Synthesis and biological evaluation of novel 1-(aryl-aldehyde-oxime)uracil derivatives as a new class of thymidine phosphorylase inhibitors. European Journal of Medicinal Chemistry 2018;144:41-51. [DOI: 10.1016/j.ejmech.2017.12.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
16 Li W, Yue H. Thymidine phosphorylase: A potential new target for treating cardiovascular disease. Trends Cardiovasc Med 2018;28:157-71. [PMID: 29108898 DOI: 10.1016/j.tcm.2017.10.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
17 Bera H, Chigurupati S. Recent discovery of non-nucleobase thymidine phosphorylase inhibitors targeting cancer. European Journal of Medicinal Chemistry 2016;124:992-1003. [DOI: 10.1016/j.ejmech.2016.10.032] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
18 Balaev VV, Lashkov AA, Prokofev II, Gabdulkhakov AG, Seregina TA, Mironov AS, Betzel C, Mikhailov AM. Substrate specificity of pyrimidine nucleoside phosphorylases of NP-II family probed by X-ray crystallography and molecular modeling. Crystallogr Rep 2016;61:830-41. [DOI: 10.1134/s1063774516050023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Karyampudi A, Srivastava P, Mandal K, Yadav P, Ghoshal UC, Verma A, Phadke SR. Novel sequence variations in the thymidine phosphorylase gene causing mitochondrial neurogastrointestinal encephalopathy. Clin Dysmorphol 2016;25:156-62. [PMID: 27261974 DOI: 10.1097/MCD.0000000000000137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
20 Balaev VV, Lashkov AA, Gabdulkhakov AG, Dontsova MV, Seregina TA, Mironov AS, Betzel C, Mikhailov AM. Structural investigation of the thymidine phosphorylase from Salmonella typhimurium in the unliganded state and its complexes with thymidine and uridine. Acta Crystallogr F Struct Biol Commun 2016;72:224-33. [PMID: 26919527 DOI: 10.1107/S2053230X1600162X] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
21 Bensaber SM, Allafe HA, Ermeli NB, Mohamed SB, Zetrini AA, Alsabri SG, Erhuma M, Hermann A, Jaeda MI, Gbaj AM. Chemical synthesis, molecular modelling, and evaluation of anticancer activity of some pyrazol-3-one Schiff base derivatives. Med Chem Res 2014;23:5120-34. [DOI: 10.1007/s00044-014-1064-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 4.1] [Reference Citation Analysis]
22 Bera H, Ojha PK, Tan BJ, Sun L, Dolzhenko AV, Chui W, Chiu GNC. Discovery of mixed type thymidine phosphorylase inhibitors endowed with antiangiogenic properties: Synthesis, pharmacological evaluation and molecular docking study of 2-thioxo-pyrazolo[1,5-a][1,3,5]triazin-4-ones. Part II. European Journal of Medicinal Chemistry 2014;78:294-303. [DOI: 10.1016/j.ejmech.2014.03.063] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
23 Bera H, Dolzhenko AV, Sun L, Dutta Gupta S, Chui WK. Synthesis and in vitro evaluation of 1,2,4-triazolo[1,5-a][1,3,5]triazine derivatives as thymidine phosphorylase inhibitors. Chem Biol Drug Des 2013;82:351-60. [PMID: 23758794 DOI: 10.1111/cbdd.12171] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
24 Timofeev V, Abramchik Y, Zhukhlistova N, Muravieva T, Fateev I, Esipov R, Kuranova I. 3'-Azidothymidine in the active site of Escherichia coli thymidine phosphorylase: the peculiarity of the binding on the basis of X-ray study. Acta Crystallogr D Biol Crystallogr 2014;70:1155-65. [PMID: 24699659 DOI: 10.1107/S1399004714001904] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
25 Deves C, Rostirolla DC, Martinelli LK, Bizarro CV, Santos DS, Basso LA. The kinetic mechanism of Human Thymidine Phosphorylase - a molecular target for cancer drug development. Mol Biosyst 2014;10:592-604. [PMID: 24407036 DOI: 10.1039/c3mb70453j] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
26 Timofeev VI, Abramchik YA, Fateev IV, Zhukhlistova NE, Murav’eva TI, Kuranova IP, Esipov RS. Three-dimensional structure of thymidine phosphorylase from E. coli in complex with 3′-azido-2′-fluoro-2′,3′-dideoxyuridine. Crystallogr Rep 2013;58:842-53. [DOI: 10.1134/s1063774513060230] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
27 Bera H, Lee MH, Sun L, Dolzhenko AV, Chui WK. Synthesis, anti-thymidine phosphorylase activity and molecular docking of 5-thioxo-[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-ones. Bioorg Chem 2013;50:34-40. [PMID: 23968897 DOI: 10.1016/j.bioorg.2013.07.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
28 Bera H, Chui W, Gupta SD, Dolzhenko AV, Sun L. Synthesis, in vitro evaluation of thymidine phosphorylase inhibitory activity, and in silico study of 1,3,5-triazin-2,4-dione and its fused analogues. Med Chem Res 2013;22:6010-21. [DOI: 10.1007/s00044-013-0589-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
29 Kamatani N, Jinnah H, Hennekam RC, van Kuilenburg AB. Purine and Pyrimidine Metabolism. Emery and Rimoin's Principles and Practice of Medical Genetics 2013. [DOI: 10.1016/b978-0-12-383834-6.00099-9] [Reference Citation Analysis]
30 Zhang VW. Protein Structural Based Analysis for Interpretation of Missense Variants at the Genomics Era: Using MNGIE Disease as an Example. Next Generation Sequencing 2013. [DOI: 10.1007/978-1-4614-7001-4_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
31 Schwartz PA, Vetticatt MJ, Schramm VL. Transition state analysis of the arsenolytic depyrimidination of thymidine by human thymidine phosphorylase. Biochemistry 2011;50:1412-20. [PMID: 21222488 DOI: 10.1021/bi101900b] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
32 Schwartz PA, Vetticatt MJ, Schramm VL. Transition state analysis of thymidine hydrolysis by human thymidine phosphorylase. J Am Chem Soc 2010;132:13425-33. [PMID: 20804144 DOI: 10.1021/ja105041j] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
33 Przybylski JL, Wetmore SD. Modeling the dissociative hydrolysis of the natural DNA nucleosides. J Phys Chem B 2010;114:1104-13. [PMID: 20039632 DOI: 10.1021/jp9098717] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]